GcMAF Therapy Indication

What diseases can benefit from GcMAF therapy?

Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune disfunction or where the immune system is compromised, such as:

CancerAutoimmune diseasesEpstein-Barr Virus (EBV)
Hepatitis B virus (HBV)Herpes Simplex virus (HSV)Cystitis
Hepatitis C virus (HCV)Multiple sclerosis (MS)Urinary tract infection (UTI)
Autism Spectrum Disorders (ASD)Rheumatoid arthritis (RA)Endometriosis
Chronic Fatigue Syndrome (CFS)Lyme disease (Lyme borreliosis)IgA deficiency disorder
Myalgic Encephalomyelitis (ME)Mycobacteria infectionsParkinson's disease
TuberculosisFibromyalgiaHuman papillomavirus (HPV)
Lupus (Systemic lupus erythematosus, SLE)HIV AIDSDengue fever
Pneumonia infectionWarts caused by viral infectionNorovirus
MalariaInfluenza virus (flu)Herpes simplex virus (HSV)
Q fever (Coxiella burnetii)Polycystic ovary syndrome (PCOS)Chicken pox (varicella zoster virus)
PsoriasisRespiratory tract infectionsUlcerative colitis, Crohn's disease
Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM)Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA)